Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v17-FR | Version v6-FR | |
---|---|---|
Language | French | French |
Date Updated | 2018-10-01 | 2018-08-03 |
Drug Identification Number | 00386685 | 00386685 |
Brand name | LIPIODOL ULTRA FLUID | LIPIODOL ULTRA FLUID |
Common or Proper name | Ethiodized Oil Injection | Ethiodized Oil Injection |
Company Name | GUERBET | GUERBET |
Ingredients | IODINE | IODINE |
Strength(s) | 380MG | 380MG |
Dosage form(s) | LIQUID | LIQUID |
Route of administration | PARENTERAL (UNSPECIFIED) INTRACAVITARY | PARENTERAL (UNSPECIFIED) INTRACAVITARY |
Packaging size | 10 mL | 10 mL |
ATC code | V08AD | V08AD |
ATC description | X-RAY CONTRAST MEDIA, IODINATED | X-RAY CONTRAST MEDIA, IODINATED |
Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
Anticipated start date | 2018-08-10 | 2018-08-10 |
Actual start date | ||
Estimated end date | 2018-10-05 | 2018-09-14 |
Actual end date | ||
Shortage status | Actual shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Delay in shipping of the drug, currently in transit. Limited inventory is available; however, distribution will temporarily be on an allocation basis. We anticipate meeting demand once the next lot is released. For more information, please contact Methapharm at 1-800-287-7686, sales@methapharm.com, or fax 519-751-9149. | Inventory is currently available; however, distribution will temporarily be on an allocation basis. We anticipate meeting demand once the next lot is released. For more information, please contact Methapharm at 1-800-287-7686, sales@methapharm.com, or fax 519-751-9149. |
Health Canada comments |